Ethics and the Pharmaceutical Industry

ISBN-10: 0521708885
ISBN-13: 9780521708883
Edition: 2007
List price: $40.99 Buy it from $40.93
This item qualifies for FREE shipping

*A minimum purchase of $35 is required. Shipping is provided via FedEx SmartPost® and FedEx Express Saver®. Average delivery time is 1 – 5 business days, but is not guaranteed in that timeframe. Also allow 1 - 2 days for processing. Free shipping is eligible only in the continental United States and excludes Hawaii, Alaska and Puerto Rico. FedEx service marks used by permission."Marketplace" orders are not eligible for free or discounted shipping.

30 day, 100% satisfaction guarantee

If an item you ordered from TextbookRush does not meet your expectations due to an error on our part, simply fill out a return request and then return it by mail within 30 days of ordering it for a full refund of item cost.

Learn more about our returns policy

Description: Despite the pharmaceutical industry's notable contributions to human progress, including the development of miracle drugs for treating cancer, AIDS, and heart disease, there is a growing tension between the industry and the public. Debates are  More...

New Starting from $41.97
what's this?
Rush Rewards U
Members Receive:
coins
coins
You have reached 400 XP and carrot coins. That is the daily max!
You could win $10,000

Get an entry for every item you buy, rent, or sell.

Study Briefs

Limited time offer: Get the first one free! (?)

All the information you need in one place! Each Study Brief is a summary of one specific subject; facts, figures, and explanations to help you learn faster.

Add to cart
Study Briefs
Medical Terminology Online content $4.95 $1.99
Add to cart
Study Briefs
Medical Math Online content $4.95 $1.99
Add to cart
Study Briefs
Careers in Medical Assisting Online content $4.95 $1.99

Customers also bought

Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading

Book details

List price: $40.99
Copyright year: 2007
Publisher: Cambridge University Press
Publication date: 7/23/2007
Binding: Paperback
Pages: 528
Size: 6.00" wide x 9.00" long x 1.25" tall
Weight: 0.682
Language: English

Despite the pharmaceutical industry's notable contributions to human progress, including the development of miracle drugs for treating cancer, AIDS, and heart disease, there is a growing tension between the industry and the public. Debates are raging over how the industry can and should be expected to act. In this volume leading figures in industry, government, NGOs, the medical community, and academia discuss and propose solutions to the ethical dilemmas of drug industry behavior. They examine such aspects as the role of intellectual property rights and patent protection, the moral and economic requisites of research and clinical trials, drug pricing, marketing and advertising. . Michael Santoro is Associate Professor with tenure in the Business Environment Department at Rutgers Business School, where he teaches courses on business ethics, public policy, labor and human rights, law, ethical issues in the pharmaceutical industry and China business strategy. As a Research Associate at Harvard Business School, he wrote or co-authored nearly thirty case studies and teaching notes on ethical and legal topics such as global protection of intellectual property, insider trading, the Federal Sentencing Guidelines and Fair Credit Reporting Act. Thomas Gorrie is Corporate Vice President, Government Affairs & Policy, at Johnson & Johnson, with responsiblity for all federal, state and international government affairs and policy. He completed post-doctoral studies at the Swiss Federal Institute of Technology in Zurich, following the receipt of his doctorate at Princeton University. Gorrie has over 30 years of worldwide health care experience and has worked with various Johnson & Johnson companies in research and development, marketing and sales, business development, strategic planning, general management, international, venture capital, and health policy.

Thomas M. Gorrie is Corporate Vice President, Government Affairs & Policy at Johnson & Johnson, with responsibility as Corporate Officer for all federal, state, and international government affairs and policy. He has over 30 years of worldwide health care experience. He has worked with various Johnson & Johnson companies in research and development, marketing and sales, business development, strategic planning, general management, international venture capital, and health policy. Dr Gorrie received his Ph.D. in chemistry from Princeton University. He completed post-doctoral studies at the Swiss Federal Institute of Technology in Zurich. He serves on numerous non-profit boards, including Duke University Health Care System, Robert Wood Johnson University Hospital, the Dean's Advisory Board of the Rutgers Business School, and the Hun School of Princeton.

Charting a sustainable path for the 21st century pharmaceutical industry
Profits, Patients' Rights, and Scientific Progress: The Ethics of Clinical Research Conducted in Private Enterprises
Drug research: between ethical demands and economic constraints
Emerging international norms for clinical testing: good clinical trial practice
The regulatory and ethical challenges of pediatric research
Including children in research: participation or exploitation?
Racial and ethnic inclusiveness in clinical trials Valentine
The rights of patients to participate in clinical trials
How should government regulate stem-cell research? perspectives of a scientist-legislator The
Marketing and the Efficient Utilization of Healthcare Resources: Ethical and Public Policy Challenges
Ethics and prescribing: the clinician's perspective Charles L. Bardes
Direct-to-consumer advertising of prescription drugs: a policy dilemma
Regulation of prescription drug promotion
Off-label communications in marketing prescription drugs
The need for better health information: advancing the informed patient in Europe
Who should get access to which drugs? An ethical template for pharmacy benefits
The application of cost-effectiveness and cost-benefit analysis to pharmaceuticals
Patents, Pricing, and Equal Access
Intellectual property rights, access to life-enhancing drugs, and corporate moral responsibilities
A future agenda for government-industry relations
AIDS activism and the pharmaceutical industry
The campaign against innovation
Third world perspectives on global pharmaceutical access
The promise of vaccines and the influenza shortage of 2004: public and private partnerships
Charting a Sustainable Path for the 21st Century
Evolving approaches to healthcare challenges
Property rights in crisis: managers and rescue
Blurring the lines: public and private partnerships addressing global health
Renegotiating the grand bargain: balancing prices, profits, people, and principles

×
Free shipping on orders over $35*

*A minimum purchase of $35 is required. Shipping is provided via FedEx SmartPost® and FedEx Express Saver®. Average delivery time is 1 – 5 business days, but is not guaranteed in that timeframe. Also allow 1 - 2 days for processing. Free shipping is eligible only in the continental United States and excludes Hawaii, Alaska and Puerto Rico. FedEx service marks used by permission."Marketplace" orders are not eligible for free or discounted shipping.

Learn more about the TextbookRush Marketplace.

×